Zions Bancorporation’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-21
| Closed | -$1.83K | – | 929 |
|
|
2024
Q1 | $1.83K | Hold |
21
| – | – | ﹤0.01% | 838 |
|
|
2023
Q4 | $2.02K | Hold |
21
| – | – | ﹤0.01% | 822 |
|
|
2023
Q3 | $1.86K | Hold |
21
| – | – | ﹤0.01% | 816 |
|
|
2023
Q2 | $1.82K | Sell |
21
-4
| -16% | -$376 | ﹤0.01% | 825 |
|
|
2023
Q1 | $2.43K | Hold |
25
| – | – | ﹤0.01% | 803 |
|
|
2022
Q4 | $2.59K | Sell |
25
-86
| -77% | -$8.07K | ﹤0.01% | 931 |
|
|
2022
Q3 | $9K | Buy |
111
+86
| +344% | +$7.66K | ﹤0.01% | 676 |
|
|
2022
Q2 | $2K | Sell |
25
-5,005
| -100% | -$398K | ﹤0.01% | 962 |
|
|
2022
Q1 | $388K | Sell |
5,030
-1,254
| -20% | -$105K | 0.03% | 268 |
|
|
2021
Q4 | $555K | Buy |
6,284
+662
| +12% | +$54.6K | 0.05% | 214 |
|
|
2021
Q3 | $435K | Buy |
5,622
+836
| +17% | +$66K | 0.04% | 215 |
|
|
2021
Q2 | $399K | Buy |
4,786
+552
| +13% | +$43.8K | 0.04% | 206 |
|
|
2021
Q1 | $320K | Buy |
4,234
+691
| +20% | +$56.4K | 0.04% | 214 |
|
|
2020
Q4 | $311K | Sell |
3,543
-38
| -1% | -$3.01K | 0.04% | 194 |
|
|
2020
Q3 | $272K | Sell |
3,581
-2,536
| -41% | -$257K | 0.04% | 176 |
|
|
2020
Q2 | $754K | Buy |
6,117
+563
| +10% | +$56K | 0.11% | 82 |
|
|
2020
Q1 | $469K | Buy |
5,554
+3,709
| +201% | +$320K | 0.08% | 95 |
|
|
2019
Q4 | $156K | Sell |
1,845
-244
| -12% | -$18.4K | 0.02% | 266 |
|
|
2019
Q3 | $141K | Buy |
2,089
+90
| +5% | +$6.93K | 0.02% | 293 |
|
|
2019
Q2 | $171K | Buy |
1,999
+764
| +62% | +$65.4K | 0.03% | 248 |
|
|
2019
Q1 | $110K | Buy |
1,235
+40
| +3% | +$3.71K | 0.02% | 296 |
|
|
2018
Q4 | $102K | Buy |
1,195
+1,039
| +666% | +$98.8K | 0.07% | 125 |
|
|
2018
Q3 | $15K | Buy |
156
+15
| +11% | +$1.5K | ﹤0.01% | 523 |
|
|
2018
Q2 | $13K | Buy |
141
+15
| +12% | +$1.31K | 0.01% | 313 |
|
|
2018
Q1 | $10K | Sell |
126
-826
| -87% | -$70.9K | ﹤0.01% | 407 |
|
|
2017
Q4 | $85K | Buy |
952
+34
| +4% | +$2.96K | 0.01% | 258 |
|
|
2017
Q3 | $85K | Buy |
918
+878
| +2,195% | +$77.6K | 0.01% | 459 |
|
|
2017
Q2 | $4K | Sell |
40
-53
| -57% | -$4.82K | ﹤0.01% | 462 |
|
|
2017
Q1 | $7K | Buy |
93
+1
| +1% | +$89 | ﹤0.01% | 434 |
|
|
2016
Q4 | $8K | Buy |
92
+35
| +61% | +$3.01K | ﹤0.01% | 546 |
|
|
2016
Q3 | $5K | Hold |
57
| – | – | ﹤0.01% | 591 |
|
|
2016
Q2 | $5K | Hold |
57
| – | – | ﹤0.01% | 562 |
|
|
2016
Q1 | $5K | Buy |
57
+29
| +104% | +$2.36K | ﹤0.01% | 631 |
|
|
2015
Q4 | $2K | Hold |
28
| – | – | ﹤0.01% | 703 |
|
|
2015
Q3 | $3K | Buy |
+28
| New | +$3.74K | ﹤0.01% | 673 |
|
|
2015
Q2 | – | Sell |
-28
| Closed | -$3K | – | 318 |
|
|
2015
Q1 | $3K | Buy |
+28
| New | +$2.97K | ﹤0.01% | 714 |
|
Other funds holding BMRN
ACA
